Delivery Order SPE2DB22D3401-SPE2DB24FT3QW

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,043.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOVAZA 1 GM CAPSULE 120S, a pharmaceutical product, with a completion date of May 27, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOVAZA 1 GM CAPSULE 120S, a prescription medication. The award has a ceiling value of $4,609.76 and a period of performance through June 6, 2025. AmerisourceBergen Drug Corp is the prime contractor for this award, which is not set aside. The company holds a significant...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $40,049.44 to Amerisourcebergen Drug Corporation for the provision of 1,200 Lovaza 1 gram capsules to support Defense Department requirements. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 13, 2023 under the terms of the order. No subcontractors or set-aside designations were identified. The award draws upon the Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.84 Firm Fixed Price Delivery Order is for the supply of LIVALO 2 MG TABLET 90S, a pharmaceutical product, with a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.20 firm fixed price delivery order is for pharmaceutical and medical products to support federal agencies, particularly the military and veteran healthcare systems. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,632.06 firm fixed-price delivery order is for the supply of pharmaceutical and medical products to support military healthcare programs. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award is for $72,145.64 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price delivery order with a completion date of June 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,564.37 firm-fixed-price delivery order contract is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains, to support military healthcare programs worldwide. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,580.11 firm fixed-price delivery order contract, which does not have a set-aside designation, is for the delivery of various pharmaceutical and medical products to support federal agencies, with a focus on military and veteran healthcare programs. The contract is part of a larger $999,999,999.00 Indefinite...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT3QW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,023.68 firm fixed-price delivery order contract is for the supply of LOVAZA 1 GM CAPSULE 120S, a medical product.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:43 AM